Figures computed from official regulatory filings — .
Analysttarget 35.73 USD (+120%) · consensus 4.65/5 · 16 buy · 0 hold · 1 sell
Ownershipinsiders 0.24% · institutions 103.61% · short 17.8% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for DYNEGY INC. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Market information source · Oct 19, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 19, 2026
Open-market timeline · full history
67 buys452 sellsbar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Daley Martin W. | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Petrone Sheree M. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Callaway Catherine B. | Other | n/a (No price was disclosed in the filing) | SEC |
| Cox Julius | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| FLEXON ROBERT Ctrack record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Walden John Clinton | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Petrone Sheree M. | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Burke Carolyn Jeanne | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Walden John Clinton | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Daley Martin W. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Jones Henry D. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Freeland Clinttrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Walden John Clinton | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Ellis Dean | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Daley Martin W. | Other | n/a (No price was disclosed in the filing) | SEC |
| Daley Martin W. | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Jones Henry D. | Other | n/a (No price was disclosed in the filing) | SEC |
| Jones Henry D. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Walden John Clinton | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Stein Jeffrey Scott | Other | n/a (No price was disclosed in the filing) | SEC |
| Cox Julius | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| BARBAS PAUL Mtrack record | Other | n/a (No price was disclosed in the filing) | SEC |
| Burke Carolyn Jeanne | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Freeland Clinttrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Callaway Catherine B. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |